Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal lung morphology (HP:0002088)help
Parent Node:
expand
Pulmonary interstitial high-resolution computed tomography abnormality (HP:0025389)help
Parent Node:
expand
Pulmonary opacity (HP:0031457)help
..Starting node
..expand
Ground-glass opacification (HP:0025179)help
Term ID: 25179
Name: Ground-glass opacification
Synonym: GGO; Ground glass opacities; Ground-glass opacification on pulmonary HRCT
Definition: On chest radiographs, ground-glass opacity appears as an area of hazy increased lung opacity, usually extensive, within whichnmargins of pulmonary vessels may be indistinct. On CT scans, it appears as hazy increased opacity of lung, with preservation of bronchial and vascular margins. It is caused by partial filling of airspaces, interstitial thickening (due to fluid, cells, and/or fibrosis), partial collapse of alveoli, increased capillary blood volume, or a combination of these, the common factor being the partial displacement of air. Ground-glass opacity is less opaque than consolidation, in which bronchovascular margins are obscured.
Comments:
Reference: HP:0025179
Genes and Diseases:
 
       Child Nodes:
........expandCentrilobular ground-glass opacification on pulmonary HRCT (HP:0025180) help

 Sister Nodes: 
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0025179HP:0025179Ground-glass opacification0ABCA3 CL E G H2133ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent147
HP:0025179HP:0025179Ground-glass opacification0ABCA3 CL E G H2133OMIM:610921Surfactant metabolism dysfunction, pulmonary, 3147
HP:0025179HP:0025179Ground-glass opacification0ATP11A CL E G H2325013552ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent
HP:0025179HP:0025179Ground-glass opacification0BMPR2 CL E G H6591078OMIM:265450PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT; PVOD1525
HP:0025179HP:0025179Ground-glass opacification0CSF2RA CL E G H14382435OMIM:300770SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP415
HP:0025179HP:0025179Ground-glass opacification0CSF2RB CL E G H14392436OMIM:614370SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5; SMDP517
HP:0025179HP:0025179Ground-glass opacification0DPP9 CL E G H9103918648ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent
HP:0025179HP:0025179Ground-glass opacification0DSP CL E G H18323052ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent747
HP:0025179HP:0025179Ground-glass opacification0EIF2AK4 CL E G H44027519687ORPHA:199241Pulmonary capillary hemangiomatosisHP:0040281 - Very frequent40
HP:0025179HP:0025179Ground-glass opacification0EIF2AK4 CL E G H44027519687OMIM:234810PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD240
HP:0025179HP:0025179Ground-glass opacification0FAM13A CL E G H1014419367ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent
HP:0025179HP:0025179Ground-glass opacification0HLA-DPB1 CL E G H31154940ORPHA:133Chronic beryllium diseaseHP:0040282 - Frequent1
HP:0025179HP:0025179Ground-glass opacification0IFIH1 CL E G H6413518873OMIM:619773IMMUNODEFICIENCY 95; IMD9528
HP:0025179HP:0025179Ground-glass opacification0MUC5B CL E G H7278977516ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent133
HP:0025179HP:0025179Ground-glass opacification0NKX2-1 CL E G H708011825OMIM:610978Choreoathetosis, hypothyroidism, and neonatal respiratory distress51
HP:0025179HP:0025179Ground-glass opacification0PARN CL E G H50738609ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent26
HP:0025179HP:0025179Ground-glass opacification0RTEL1 CL E G H5175015888ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent77
HP:0025179HP:0025179Ground-glass opacification0SFTPA1 CL E G H65350910798ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent19
HP:0025179HP:0025179Ground-glass opacification0SFTPA1 CL E G H65350910798OMIM:619611INTERSTITIAL LUNG DISEASE 1; ILD119
HP:0025179HP:0025179Ground-glass opacification0SFTPA2 CL E G H72923810799ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent10
HP:0025179HP:0025179Ground-glass opacification0SFTPB CL E G H643910801OMIM:265120Surfactant metabolism dysfunction, pulmonary, 151
HP:0025179HP:0025179Ground-glass opacification0SFTPC CL E G H644010802ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent33
HP:0025179HP:0025179Ground-glass opacification0SFTPC CL E G H644010802OMIM:610913Surfactant metabolism dysfunction, pulmonary, 233
HP:0025179HP:0025179Ground-glass opacification0SLC34A2 CL E G H1056811020ORPHA:60025Pulmonary alveolar microlithiasisHP:0040284 - Very rare7
HP:0025179HP:0025179Ground-glass opacification0STN1 CL E G H7999126200ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent2
HP:0025179HP:0025179Ground-glass opacification0TERC CL E G H701211727ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent48
HP:0025179HP:0025179Ground-glass opacification0TERT CL E G H701511730ORPHA:2032Idiopathic pulmonary fibrosisHP:0040282 - Frequent238
HP:0025179HP:0032983Atoll sign1 CL E G H
HP:0025179HP:0032971Computed tomographic halo sign1 CL E G H
HP:0025179HP:0025180Centrilobular ground-glass opacification on pulmonary HRCT1BMPR2 CL E G H6591078OMIM:265450PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT; PVOD1525
HP:0025179HP:0025180Centrilobular ground-glass opacification on pulmonary HRCT1EIF2AK4 CL E G H44027519687ORPHA:199241Pulmonary capillary hemangiomatosisHP:0040282 - Frequent40
HP:0025179HP:0025180Centrilobular ground-glass opacification on pulmonary HRCT1EIF2AK4 CL E G H44027519687OMIM:234810PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD240


Genes (23) :ABCA3 ATP11A BMPR2 CSF2RA CSF2RB DPP9 DSP EIF2AK4 FAM13A HLA-DPB1 IFIH1 MUC5B NKX2-1 PARN RTEL1 SFTPA1 SFTPA2 SFTPB SFTPC SLC34A2 STN1 TERC TERT

Diseases (14) :ORPHA:2032 OMIM:610921 OMIM:265450 OMIM:300770 OMIM:614370 ORPHA:199241 OMIM:234810 ORPHA:133 OMIM:619773 OMIM:610978 OMIM:619611 OMIM:265120 OMIM:610913 ORPHA:60025
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.